Post-traumatic Stress Disorder
📧 Sign up to get email alerts when something new happens for Post-traumatic Stress Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-27Clinical Trial Update: Adolescent PCIP Randomized Feasibility Trial [NA]
The Adolescent PCIP randomized feasibility trial has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-02-04Clinical Trial Update: The Sequestration of Holistic Stress Management Techniques for Adults [NA]
A clinical trial evaluating holistic stress management techniques for adults has been withdrawn; the associated condition focus included pos…
-
CLINICAL_TRIALS withdrawal · 2026-01-05Clinical Trial Update: Common Factors Group Psychotherapy for General Mental Health Concerns [NA]
A clinical trial evaluating common factors group psychotherapy for general mental health concerns has been withdrawn, with target conditions…
-
CLINICAL_TRIALS withdrawal · 2025-12-23Clinical Trial Update: Consequences of the QUARANTINE Relating to the COvid-19 Epidemic on the Mental Health of the Patients Followed in PSYchiatry
A clinical trial sponsored by University Hospital Lille (NCT04405362) was withdrawn; it planned to study the mental health impact of quarant…
-
CLINICAL_TRIALS withdrawal · 2025-09-08Clinical Trial Update: Efficacy of Traumatic Memory Modification Using Memory Reconsolidation and Propranolol Among Adolescents With PTSD [Phase 2]
Phase 2 trial evaluating memory reconsolidation with propranolol for adolescents with post-traumatic stress disorder has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-08-22Clinical Trial Update: Trifecta Research Study [Phase 2]
Johns Hopkins University's Phase 2 clinical trial was withdrawn from the registry. The withdrawal applies to conditions including post-traum…
-
CLINICAL_TRIALS withdrawal · 2025-08-06Clinical Trial Update: Adaptation of the PCIP for Spanish Speaking Adolescents and Families [NA]
A UCLA-sponsored clinical trial adaptation of the PCIP for Spanish-speaking adolescents and families has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-08-06Clinical Trial Update: Adaptation of the PCIP for Children Aged 6 to 11 [NA]
Clinical trial update shows the study adapting the PCIP for children aged 6 to 11 has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-04-10Clinical Trial Update: MDMA-Assisted Psychotherapy for Treatment Resistant PTSD in Adolescents [Phase 2]
A Phase 2 study of MDMA-assisted psychotherapy for treatment-resistant post-traumatic stress disorder in adolescents has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-03-30Clinical Trial Update: Pranayama for Posttraumatic Stress Disorder [NA]
A clinical trial investigating pranayama for posttraumatic stress disorder sponsored by Universität Duisburg-Essen has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-03-13Clinical Trial Update: Identification of Post-Traumatic Stress Disorder in Adult Patients With Substance Use Disorders [NA]
The clinical trial investigating identification of PTSD in adults with substance use disorders has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-12-24Clinical Trial Update: Trauma-Focused Intervention With Women Experiencing Homelessness [Phase 1]
A Phase 1 trial evaluating a trauma-focused intervention for women experiencing homelessness has been withdrawn from clinicalTrials.gov, spo…
-
CLINICAL_TRIALS withdrawal · 2024-11-05Clinical Trial Update: A Multi-site Expanded Access Program for MDMA-assisted Psychotherapy for Patients With Treatment-resistant PTSD
Expanded access program of MDMA-assisted psychotherapy for treatment-resistant PTSD across multiple sites is no longer available.
-
CLINICAL_TRIALS withdrawal · 2024-10-30Clinical Trial Update: Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans [Phase 2]
The Phase 2 trial evaluating MDMA-assisted group therapy for PTSD in veterans has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-26Clinical Trial Update: Life With Covid Since 2020: a Randomized Control Trial of a Real-time Data Collection Smartphone-based App Assessing and Treating the Covid-19 Psychological Impacts [NA]
A randomized controlled trial evaluating a real-time smartphone app to assess and treat Covid-19–related psychological impacts in individual…
-
CLINICAL_TRIALS withdrawal · 2024-05-17Clinical Trial Update: The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD. [Phase 1]
A Phase 1 trial evaluating the effects of MDMA on prefrontal and amygdala activation in individuals with PTSD was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-09Clinical Trial Update: Integration of PE & Coping Long-Term With Active Suicide Program for PTSD & Suicide Risk in Military Families [NA]
This clinical trial evaluating prolonged exposure-based therapy plus coping strategies for PTSD and suicide risk in military families has be…
-
CLINICAL_TRIALS withdrawal · 2024-05-07Clinical Trial Update: Targeted Group-based Psychotherapy to Address Emotional Stress in at Risk ICU Survivors [NA]
A clinical trial studying targeted group-based psychotherapy for emotional stress in at-risk ICU survivors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-03Clinical Trial Update: First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM) [Phase 1]
The first-in-human single ascending dose study of FluoroEthylNorMemantine (FENM) by ReST Therapeutics has been withdrawn; the listed conditi…
-
CLINICAL_TRIALS withdrawal · 2024-05-03Clinical Trial Update: Warrior CARE: Naturalistic Observation and Harm Reduction [NA]
A Wayne State University study (NCT05386862) investigating naturalistic observation and harm reduction for post-traumatic stress disorder an…
-
CLINICAL_TRIALS withdrawal · 2023-02-08Clinical Trial Update: Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD [Phase 2, Phase 3]
Clinical trial investigating D-cycloserine with imagery rescripting for subclinical PTSD has been withdrawn after Phase 2/3.
-
CLINICAL_TRIALS withdrawal · 2022-06-03Clinical Trial Update: Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder [Phase 2, Phase 3]
A clinical trial studying nabiximols Oromucosal spray for PTSD has been withdrawn after Phase 2/3 development.
-
CLINICAL_TRIALS withdrawal · 2020-11-16Clinical Trial Update: The Use of Anticonvulsants for Treatment of Patients With Alcohol Dependence and Post Traumatic Stress Disorder [Phase 3]
Phase 3 trial on anticonvulsants for alcohol dependence with PTSD has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-01-18Clinical Trial Update: Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel
A clinical trial from Uniformed Services University investigating dementia types that may occur after traumatic brain injury in retired mili…
-
CLINICAL_TRIALS withdrawal · 2018-04-09Clinical Trial Update: FamilyLive Feasibility and Effectiveness Study [EARLY_Phase 1]
The FamilyLive feasibility and effectiveness study in mood lability and PTSD/Anxiety has been withdrawn.